Which migraine medications are preferred for patients with anxiety, including both acute and preventive treatments?

Preferred Migraine Medications for Anxious Patients

For anxious patients requiring migraine prevention, amitriptyline should be the first-line choice, as it effectively treats both migraine and anxiety disorders simultaneously. 1, 2

Preventive Treatment Strategy

First-Line Options

Amitriptyline is the optimal single agent because it:

• Has the best evidence for migraine prevention 3, 4
• Treats comorbid anxiety and depression 2
• Provides sedating effects beneficial for comorbid insomnia 3
• Allows treatment of both conditions with one medication, avoiding polypharmacy 2

Alternative First-Line Agents

If amitriptyline is not tolerated, consider these anxiety-friendly options:

• Beta-blockers (propranolol or metoprolol): May help with anxiety symptoms, particularly physical manifestations 2, 4. These received strong recommendations in Canadian guidelines 4 and are included in the 2025 ACP guideline first-trial recommendations 5

• Venlafaxine (SNRI): Most effective when both depression and anxiety coexist with migraine 2, 3. The 2025 ACP guideline includes this as a first-trial option 5

• Flunarizine: May help when anxiety is present 2

Medications to AVOID in Anxious Patients

Do not use topiramate as first-line despite its strong efficacy evidence 1, 5. While it's often recommended as first choice due to cost 1, it can worsen psychiatric comorbidities and should be avoided when mood or anxiety disorders are present 2.

Second-Line and Refractory Options

For patients failing first-line treatments:

• Pregabalin: Has demonstrated efficacy in anxiety disorders and may benefit migraine with comorbid anxiety 2
• Divalproex sodium: Effective for mood stabilization and migraine prevention 2, 4
• CGRP monoclonal antibodies: Consider when multiple preventives have failed, though no specific anxiety benefit 1, 5

Acute Treatment Considerations

For acute migraine attacks in anxious patients, standard acute treatments (triptans, NSAIDs) can be used without concern for worsening anxiety 6. The anxiety comorbidity primarily influences preventive medication selection, not acute treatment choices.

Clinical Algorithm

1. Screen for anxiety/depression in all patients with frequent episodic or chronic migraine 1
2. Start amitriptyline unless contraindicated (cardiac issues, urinary retention, narrow-angle glaucoma)
3. If amitriptyline fails or not tolerated: Try beta-blocker (propranolol/metoprolol) or venlafaxine
4. Avoid topiramate as initial choice in this population
5. Consider CGRP antibodies only after 2-3 preventive failures 1

Important Caveats

The 2021 Nature Reviews guideline emphasizes that recognition of comorbidities is essential because they directly influence drug choice 1. The goal is selecting medications that improve both migraine and the psychiatric comorbidity simultaneously, rather than treating them as separate conditions 2.

Common pitfall: Using topiramate first-line due to cost considerations without adequately screening for psychiatric comorbidities, which can worsen outcomes 1, 2.

The evidence strongly supports that when psychiatric comorbidities exist, both conditions should ideally be treated with a single agent to improve adherence and outcomes 2.